Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Clinical Trial

Published on 14 Dec 2020

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose and Food Effect Study to Evaluate the Tolerance, Pharmacokinetics of Jaktinib, a New Selective Janus Kinase Inhibitor in Healthy Chinese Volunteers

in Drugs Outcomes Research and Policies

Jingrui Liu
Binhua Lv
Hewen Yin
Xiaoxue Zhu
Haijing Wei
Yanhua Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2020.604314

5,474 views
26 citations

Systematic Review

Published on 14 Dec 2020

Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review

in Drugs Outcomes Research and Policies

Bruno Silva Andrade
Fernanda de Souza Rangel
Naiane Oliveira Santos
Andria dos Santos Freitas
Wagner Rodrigues de Assis Soares
Sérgio Siqueira
Debmalya Barh
Aristóteles Góes-Neto
Alexander Birbrair
Vasco Ariston de Carvalho Azevedo

Frontiers in Pharmacology

doi 10.3389/fphar.2020.590598

14,461 views
24 citations

Original Research

Published on 11 Dec 2020

Increasing Trends in Opioid Use From 2010 to 2018 in the Region of Valencia, Spain: A Real-World, Population-Based Study

in Drugs Outcomes Research and Policies

Isabel Hurtado
Aníbal García-Sempere
Salvador Peiró
Gabriel Sanfélix-Gimeno

Frontiers in Pharmacology

doi 10.3389/fphar.2020.612556

5,647 views
24 citations

Original Research

Published on 10 Dec 2020

Antidepressant Use and the Risk of Major Adverse Cardiovascular Events in Patients Without Known Cardiovascular Disease: A Retrospective Cohort Study

in Drugs Outcomes Research and Policies

Ha Young Jang
Jae Hyun Kim
Yun-Kyoung Song
Ju-Young Shin
Hae-Young Lee
Yong Min Ahn
Jung Mi Oh
In-Wha Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2020.594474

13,898 views
15 citations

Review

Published on 09 Dec 2020

Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review

in Drugs Outcomes Research and Policies

Giuliano Lo Bianco
Santi Di Pietro
Emilia Mazzuca
Aurelio Imburgia
Luca Tarantino
Giuseppe Accurso
Vincenzo Benenati
Federica Vernuccio
Claudio Bucolo
Salvatore Salomone

Frontiers in Pharmacology

doi 10.3389/fphar.2020.572168

9,448 views
17 citations

Review

Published on 08 Dec 2020

Barriers and Opportunities for Implementation of Outcome-Based Spread Payments for High-Cost, One-Shot Curative Therapies

in Drugs Outcomes Research and Policies

Sissel Michelsen
Salma Nachi
Walter Van Dyck
Steven Simoens
Isabelle Huys

Frontiers in Pharmacology

doi 10.3389/fphar.2020.594446

9,755 views
35 citations

Clinical Trial

Published on 07 Dec 2020

Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points

in Drugs Outcomes Research and Policies

Jinmei Su
Mengtao Li
Lan He
Dongbao Zhao
Weiguo Wan
Yi Liu
Jianhua Xu
Jian Xu
Huaxiang Liu
Lindi Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2020.606497

3,287 views
3 citations

Original Research

Published on 07 Dec 2020

Mediating Effect of Self-Efficacy on the Relationship Between Medication Literacy and Medication Adherence Among Patients With Hypertension

in Drugs Outcomes Research and Policies

Zhiying Shen
Shuangjiao Shi
Siqing Ding
Zhuqing Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2020.569092

10,866 views
47 citations

Original Research

Published on 03 Dec 2020

Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data

in Drugs Outcomes Research and Policies

Elena Ramírez
Mikel Urroz
Amelia Rodríguez
Miguel González-Muñoz
Alberto Martín-Vega
Yuri Villán
Enrique Seco
Jaime Monserrat
Jesús Frías
Antonio J. Carcas

Frontiers in Pharmacology

doi 10.3389/fphar.2020.602841

7,261 views
21 citations

Review

Published on 03 Dec 2020

Hydroxychloroquine as Prophylaxis for COVID-19: A Review

in Drugs Outcomes Research and Policies

Manuela Monti
Bernadette Vertogen
Carla Masini
Caterina Donati
Claudia Lilli
Chiara Zingaretti
Gerardo Musuraca
Ugo De Giorgi
Claudio Cerchione
Alberto Farolfi

Frontiers in Pharmacology

doi 10.3389/fphar.2020.605185

68,618 views
12 citations

Original Research

Published on 03 Dec 2020

Severe Potential Drug-Drug Interactions and the Increased Length of Stay of Children in Intensive Care Unit

in Drugs Outcomes Research and Policies

Elisangela da Costa Lima
Barbara Dias Camarinha
Nathalia Cristina Ferreira Bezerra
Anderson Gonçalves Panisset
Raquel Belmino de Souza
Marcus Tolentino Silva
Luciane Cruz Lopes

Frontiers in Pharmacology

doi 10.3389/fphar.2020.555407

5,251 views
16 citations

Original Research

Published on 03 Dec 2020

Companies’ Health Technology Assessment Strategies and Practices in Australia, Canada, England, France, Germany, Italy and Spain: An Industry Metrics Study

in Drugs Outcomes Research and Policies

Ting Wang
Neil McAuslane
Lawrence Liberti
Helga Gardarsdottir
Wim Goettsch
Hubert Leufkens

Frontiers in Pharmacology

doi 10.3389/fphar.2020.594549

15,449 views
16 citations

Original Research

Published on 30 Nov 2020

Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients

in Drugs Outcomes Research and Policies

Inmaculada Guerrero-Fernández de Alba
Valentina Orlando
Valeria M. Monetti
Sara Mucherino
Antonio Gimeno-Miguel
Olga Vaccaro
Maria João Forjaz
Beatriz Poblador Plou
Alexandra Prados-Torres
Gabriele Riccardi

Frontiers in Pharmacology

doi 10.3389/fphar.2020.586187

5,373 views
25 citations

Opinion

Published on 30 Nov 2020

Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap

in Drugs Outcomes Research and Policies

Lucia Gozzo
Laura Longo
Daniela Cristina Vitale
Filippo Drago

Frontiers in Pharmacology

doi 10.3389/fphar.2020.621934

3,248 views
11 citations

Original Research

Published on 30 Nov 2020

A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China

in Drugs Outcomes Research and Policies

Nan Zhang
Nannan Shi
Siyu Li
Guoxiu Liu
Yonglong Han
Li Liu
Xin Zhang
Xiangwen Kong
Bihua Zhang
Wenpeng Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2020.574562

5,397 views
4 citations

Mini Review

Published on 30 Nov 2020

Analysis of the Costs Associated With the Elective Evaluation of Patients Labelled as Allergic to Beta-Lactams or Nonsteroidal Antiinflamatory Agents

in Drugs Outcomes Research and Policies

Miriam Sobrino-García
Esther M. Moreno
Francisco J. Muñoz-Bellido
Maria T. Gracia-Bara
Elena Laffond
Inmaculada Doña
Cristina Martín
Eva M. Macías
Sonia de Arriba
Valle Campanón

Frontiers in Pharmacology

doi 10.3389/fphar.2020.584633

3,445 views
4 citations

Navigation group

Articles

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose and Food Effect Study to Evaluate the Tolerance, Pharmacokinetics of Jaktinib, a New Selective Janus Kinase Inhibitor in Healthy Chinese Volunteers

Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review

Increasing Trends in Opioid Use From 2010 to 2018 in the Region of Valencia, Spain: A Real-World, Population-Based Study

Antidepressant Use and the Risk of Major Adverse Cardiovascular Events in Patients Without Known Cardiovascular Disease: A Retrospective Cohort Study

Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review

Barriers and Opportunities for Implementation of Outcome-Based Spread Payments for High-Cost, One-Shot Curative Therapies

Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points

Mediating Effect of Self-Efficacy on the Relationship Between Medication Literacy and Medication Adherence Among Patients With Hypertension

Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data

Hydroxychloroquine as Prophylaxis for COVID-19: A Review

Severe Potential Drug-Drug Interactions and the Increased Length of Stay of Children in Intensive Care Unit

Companies’ Health Technology Assessment Strategies and Practices in Australia, Canada, England, France, Germany, Italy and Spain: An Industry Metrics Study

Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients

Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap

A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China

Analysis of the Costs Associated With the Elective Evaluation of Patients Labelled as Allergic to Beta-Lactams or Nonsteroidal Antiinflamatory Agents